Benzodiazepine Selection and Use for Psychiatric Conditions

Introduction to Benzodiazepine Use

The American Academy of Family Physicians recommends using short-to-intermediate acting benzodiazepines at the lowest effective dose for the shortest duration possible, ideally no more than 2-4 weeks, with lorazepam preferred for acute anxiety/agitation and temazepam for insomnia 1, 2

The American Academy of Sleep Medicine suggests that cognitive behavioral therapy for insomnia (CBT-I) should be the initial intervention, not benzodiazepines, for patients with insomnia 3, 4
For sleep-onset insomnia, the American Academy of Sleep Medicine recommends using short-acting agents like triazolam (0.125-0.25 mg) or zaleplon (5-10 mg at bedtime) 5, 6
For sleep-maintenance insomnia, the American Academy of Sleep Medicine suggests using intermediate-acting agents like temazepam (7.5-30 mg, start 7.5 mg in elderly) or estazolam (0.5-2 mg, start 0.5 mg in elderly) 5, 6

The American Academy of Family Physicians recommends starting with half the standard adult dose for elderly and debilitated patients, and preferring agents with shorter half-lives and no active metabolites, such as lorazepam, oxazepam, and temazepam 1, 2, 5
The American Academy of Family Physicians advises avoiding benzodiazepines entirely in elderly patients and those with substance abuse history due to high risks of dependence, cognitive impairment, and falls 1, 2

The American Academy of Sleep Medicine warns that benzodiazepines can cause psychomotor impairment, memory disruption, and increased accident risk, especially in the elderly, and recommends avoiding combining with alcohol or other CNS depressants 5, 6
The American Academy of Family Physicians recommends using the lowest effective dose for the shortest possible duration, and exercising caution in patients with depression, respiratory compromise, or hepatic/cardiac disease 1, 2, 5, 6

The American Academy of Sleep Medicine suggests dosing benzodiazepines on an empty stomach to maximize effectiveness, and avoiding use in pregnancy and nursing 5, 6

Both diazepam and clonazepam carry risks of dependence, tolerance, and withdrawal with prolonged use, and guidelines emphasize that all benzodiazepines should be used for the shortest duration possible, ideally less than 2-4 weeks maximum, according to The Lancet Psychiatry 7
The combination of benzodiazepines with opioids should be avoided due to dangerous synergistic respiratory depression, as warned by The Lancet Psychiatry 7
Long-acting benzodiazepines like diazepam should be avoided in elderly patients with liver disease, as accumulation of active metabolites causes prolonged sedation and delirium risk, as noted in Annals of Oncology 8

The American Academy of Pediatrics recommends midazolam for acute agitation requiring immediate effect due to its rapid onset and short duration of action, with a half-life of less than 4 hours 9
Lorazepam is preferred for acute anxiety/agitation in various patient populations due to its fast onset, rapid and complete absorption, no active metabolites, and lower risk of sedation, with a terminal half-life of approximately 8-15 hours 9
The combination of a benzodiazepine plus an antipsychotic is frequently recommended for acutely agitated patients, with lorazepam being a preferred benzodiazepine option due to its predictable absorption and lack of active metabolites 9

For elderly patients, it is recommended to start with half the standard adult dose and prefer agents with shorter half-lives and no active metabolites, such as lorazepam, with a terminal half-life of approximately 8-15 hours 9
Diazepam, with a half-life of more than 20 hours and active metabolites, should be avoided in elderly patients with liver disease due to the risk of accumulation, and its use should be limited to single or intermittent dosing in anxiety and insomnia 9

The American Academy of Sleep Medicine notes that Flurazepam is the primary long-acting benzodiazepine used clinically, with a half-life exceeding 20 hours and active metabolites that significantly increase the risk of residual daytime drowsiness, particularly in elderly and debilitated patients 10
The American Academy of Sleep Medicine recommends that Triazolam, a short-acting benzodiazepine, be used at a dose of 0.125-0.25 mg, with a mean half-life less than 8 hours 10, 11
The American Academy of Sleep Medicine suggests that long-acting agents, such as Flurazepam, are generally not recommended as first-line hypnotics due to residual daytime impairment 10, 11

The American Academy of Sleep Medicine advises that long-acting benzodiazepines, such as Flurazepam, carry a risk of residual daytime drowsiness and "hangover" effects, which are substantially more common with long-acting agents 10
The American Academy of Sleep Medicine warns that abrupt discontinuation of long-acting benzodiazepines produces withdrawal symptoms, including rebound insomnia, anxiety, tremor, and rarely seizures or psychosis 10